tiprankstipranks
Advertisement
Advertisement

InspireMD Establishes New $75 Million ATM Program

Story Highlights
  • On April 3, 2026, InspireMD set up a new $75 million at-the-market equity program with BTIG.
  • The company simultaneously ended its prior $75 million ATM agreement with Piper Sandler without penalties after selling shares.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
InspireMD Establishes New $75 Million ATM Program

Claim 30% Off TipRanks

InspireMD ( (NSPR) ) has issued an announcement.

On April 3, 2026, InspireMD entered into a new Equity Distribution Agreement with BTIG, LLC to potentially sell up to $75 million of its common stock through at-the-market and negotiated transactions under an existing shelf registration. BTIG will act as sales agent on a commercially reasonable efforts basis and receive up to a 3% commission, with any proceeds intended to support the company’s operations, including R&D, sales and marketing, and working capital.

Also on April 3, 2026, the company terminated its prior at-the-market equity distribution agreement with Piper Sandler & Co., which had similarly authorized sales of up to $75 million in stock. InspireMD incurred no termination penalties, having sold 1,361,519 shares under the prior program, and will no longer offer or sell shares pursuant to the terminated facility.

The most recent analyst rating on (NSPR) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on InspireMD stock, see the NSPR Stock Forecast page.

Spark’s Take on NSPR Stock

According to Spark, TipRanks’ AI Analyst, NSPR is a Neutral.

The score is held down mainly by weak financial quality—large operating losses and materially negative cash flow despite revenue growth and improving margins. Technicals are mixed (minor near-term improvement but still below longer-term averages), valuation support is limited based on the provided P/E and lack of dividend yield, while the earnings call adds a modest positive tilt due to U.S. launch-driven growth and guidance despite higher spending and ongoing losses.

To see Spark’s full report on NSPR stock, click here.

More about InspireMD

InspireMD, Inc. is a U.S.-listed company that issues common stock on The Nasdaq Capital Market to fund its corporate activities. The company relies on at-the-market equity offering programs as a flexible financing tool to support its operations, including research and development, sales and marketing, and general working capital needs.

Average Trading Volume: 34,719

Technical Sentiment Signal: Sell

Current Market Cap: $72.07M

Learn more about NSPR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1